PA 401

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NamePA 401
Drug Alias NameGlycafilinRecombinant human CXCL8 mutantPA-401PA-04-001
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGlycosaminoglycan inhibitors
TargetsGlycosaminoglycan
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProtaffin Biotechnologie Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtaffin Biotechnologie Ag
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia